Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 16/2003

01-11-2003 | Correspondence

Pharmaceutical expenditure and therapeutic value of new medicines in Spain

Author: Josep Darba

Published in: PharmacoEconomics | Issue 16/2003

Login to get access

Excerpt

The Spanish pharmaceutical market is the seventh largest pharmaceutical market in the world and the fifth largest in the European Union in terms of value of consumption (drug prices multiplied by purchased quantities). During the period 1997– 2001, medicines were the fastest growing component of Spanish National Health System expenditure. In response, the Spanish government adopted several cost-containment measures to keep pharmaceutical expenditures under control. Despite the savings expected from these measures, pharmaceutical expenditures rose by an annual average of 8.28% in real terms, between 1997 and 2001.[1] …
Literature
1.
The pharmaceutical industry in figures [in Spanish]. Madrid: Farmaindustria, 2001
2.
General directorate of pharmacy. Summary of scripts. Years 1997, 1998, 1999, 2000, 2001 [in Spanish]. Años: Ministry of Health and Consumption, 1997, 1998, 1999, 2000, 2001
3.
Therapeutic information of the National Health System. Madrid: Ministry of Health and Consumption, 2001
4.
Law 25/1990, 20th December 1990, Boletin Oficial del Estado, number 306
Metadata
Title
Pharmaceutical expenditure and therapeutic value of new medicines in Spain
Author
Josep Darba
Publication date
01-11-2003
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 16/2003
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321160-00005

Other articles of this Issue 16/2003

PharmacoEconomics 16/2003 Go to the issue

Original Research Article

Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors

Original Research Article

Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer

Original Research Article

The cost effectiveness of Apligraf® treatment of diabetic foot ulcers

Original Research Article

Escitalopram